Diagnostic markers of endometrial cancer
The present invention (CEMARK) describes a set of robust protein biomarkers in uterine fluid samples to diagnose and preoperatively stage EC, in a more efficient and accurate manner compared to current diagnostic methods.
CEMARK will be introduced as an easy, quick and less costly diagnostic kit. Its implementation in a routine basis will prevent overdiagnosis (no need to perform invasive biopsies).
Stage of development: TRL 4, biomarkers validated in the lab.
IP: Priority EP Patent filed.
- Health technology: